Bio-Techne releases new in situ hybridization assay

By The Science Advisory Board staff writers

April 27, 2021 -- Bio-Techne has released DNAscope Assay, a new in situ hybridization assay kit.

The kit features the company's RNAscope technology, which allows for the visualization of single-molecule gene expression in intact cells and tissues, according to the firm. It includes Bio-Techne's "double-Z" probe design, chromogenic staining, and oligo probes combined with the company's proprietary signal amplification system.

DNAscope is currently intended for research use only, Bio-Techne said.

Bio-Techne licenses antibody to Xencor
Bio-Techne has licensed an antibody to Xencor for therapeutic development.
Bio-Techne launches Abby automated western system
Bio-Techne announced that its brand ProteinSimple has released Abby, its next-generation chemiluminescence system that automates traditional western blotting.
Bio-Techne launches new product for organoid, stem cell cultures
Bio-Techne has released its new Cultrex UltiMatrix Reduced Growth Factor Basement Membrane Extract (RGF BME) to support organoid and pluripotent stem...
Luminary licenses TcBuster CAR T tech from Bio-Techne
Luminary Therapeutics has signed a license agreement with Bio-Techne for the use of its TcBuster chimeric antigen receptor (CAR) T technology for the...
Bio-Techne invests in China-based cell and gene therapy media company
Bio-Techne has made an initial minority strategic equity investment in Changzhou Eminence Biotechnology. The companies will synergistically work on the...

Copyright © 2021 scienceboard.net


Conferences
BioTech Pharma Summit
September 27-28
Porto Portugal
Infectious Diseases (ID) Week 2021
September 29 - October 3
San Diego, California United States
Imaging Mass Spectrometry Society (IMSS) 3 in 2021
October 3-6
Colorado Springs, Colorado United States
Cell & Gene Meeting on the Mesa
October 10-14
Carlsbad, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter